Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2026-01-01 @ 2:04 PM
Study NCT ID:
NCT02551861
Status:
WITHDRAWN
Last Update Posted:
2016-01-15
First Post:
2015-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-06
Completion Date Type:
ESTIMATED
First Submit Date:
2015-09-15
First Submit QC Date:
None
Study First Post Date:
2015-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-14
Last Update Post Date:
2016-01-15
Last Update Post Date Type:
ESTIMATED